Joint regeneration Chandler: ease the ache and know when to call

A little gentle motion is better than a day in the chair

Begin with a few easy bends while you're sitting in a firm chair. If sharp soreness starts or the joint feels shaky, end that exercise.

When the bends feel comfortable, walk a short distance at an easy pace. Don't continue after you begin to limp or alter your normal step.

Break a heavy chore into smaller parts, with a proper rest between them. You'll be less likely to spend the evening feeling the extra strain.

A fitted brace or cane may make movement easier in a knee or hip. Have your doctor check the fit.

Years of use often explain the stiffness and soreness

Arthritis can thin the smooth cartilage that helps the bones glide with less rubbing. An old injury may leave stiffness long after it seemed fully healed.

A tendon is firm tissue connecting muscle with bone. Repeated use can make it sore, while weak muscles can leave the nearby joint carrying more strain.

Soreness can return after a long walk, several trips up the stairs, an afternoon of yard work, or many hours spent standing on a hard floor. It may ease while you rest, then come back when you're busy again.

Heat, swelling, or weakness can mean you need help now

Get prompt medical help if you have a fever and one joint is hot or badly swollen. After a fall, seek care when you can't stand safely on that leg.

When a joint suddenly appears crooked or out of place, get help quickly. Spreading numbness or a new loss of strength can't wait either.

Call your doctor soon when the ache worsens, wakes you, or is joined by unexplained weight loss. These aren't warning signs to watch at home for another week.

An exam is worthwhile when the soreness won't settle

Write down when the joint began hurting and which ordinary chores make it ache. Take a medicine list, an old X-ray report, and a short account of past care.

The doctor may check how the joint moves, how strong it feels, and where it's swollen or sore. Ask what the doctor noticed, then ask whether an X-ray would clear up anything.

Ask which care may help now, what it could cost, and how soon relief might appear. That answer can spare you wasted time and money.

Sources

1. The AAOS third-edition clinical practice guideline for non-arthroplasty management of knee osteoarthritis is the orthopedic profession's own GRADE-style appraisal of the same options a regenerative clinic sells; it is the benchmark against which any 'regenerative' claim on this topic should be read, and it rates the strongest support for exercise, weight loss and self-management rather than for injectables.

   Brophy RH, et al. — AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition.. The Journal of the American Academy of Orthopaedic Surgeons, 2022. DOI: 10.5435/JAAOS-D-21-01233.

2. A randomized trial in the New England Journal of Medicine compared physical therapy against intra-articular glucocorticoid injection for knee osteoarthritis and found physical therapy produced better WOMAC outcomes at one year. When a clinic offers an injection, the comparator that matters is not 'nothing' - it is a course of supervised exercise.

   Deyle GD, et al. — Physical Therapy versus Glucocorticoid Injection for Osteoarthritis of the Knee.. The New England journal of medicine, 2020. DOI: 10.1056/NEJMoa1905877.

3. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

4. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.. Nature medicine, 2023. DOI: 10.1038/s41591-023-02632-w.

5. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.